Legal Representation
Attorney
Katharine Tremblay
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 4, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Apr 4, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 16, 2024 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
| Jan 6, 2022 | ATRQ | I | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | Loading... |
| Jan 6, 2022 | PR.D | T | PETITION TO REVIVE DISMISSED | Loading... |
| Jan 6, 2022 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Nov 27, 2021 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Nov 26, 2021 | PETR | I | PETITION TO REVIVE-RECEIVED | Loading... |
| Nov 26, 2021 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Nov 26, 2021 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Nov 26, 2021 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Nov 26, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 12, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 12, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 12, 2021 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
| Sep 16, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 16, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 16, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 12, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 13, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 13, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 13, 2021 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Feb 23, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 21, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 1, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 21, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 27, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 21, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 1, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 2, 2021 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Feb 1, 2021 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Feb 1, 2021 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Feb 1, 2021 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Dec 28, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 28, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 26, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 31, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 31, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 11, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 24, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 22, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 22, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 21, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 16, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 16, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 16, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 16, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 15, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 15, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 15, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Detailed Classifications
Class 001
Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Plant extracts for use in the manufacture of creams, lotions and cosmetic products
Class 003
Cosmetics
Class 005
Anesthetics for non-surgical use; Balms for medical purposes; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical and medical purposes, namely, for Ophthalmology, Allergy and Immunology, Cardiovascular, and Type II Diabetes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of emollients that facilitate the delivery of pharmaceutical preparations; Emollients for medical purposes; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for ocular and intraocular surgery; Pharmaceutical preparations for the treatment and prevention of dry eye and glaucoma and other ocular disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment of ocular disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for ophthalmic conditions, allergies, immune system diseases, cardiovascular, and type II diabetes; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Topical anesthetics
Class 010
Drug delivery systems; Medical devices for nonsurgical cosmetic treatments; Medical apparatus for introducing pharmaceutical preparations into the human body
Class 025
Hats; Hoodies; Jackets; Shirts; Sweatshirts; Wearable garments and clothing, namely, shirts
Class 041
Continuing education services, namely, providing live and on-line continuing professional education seminars in the field of medicine and more specifically those fields of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes as they relate to current treatments; Continuing education services, namely, providing live and on-line continuing professional education seminars in the legal, medical, accounting, and real estate fields; Education services, namely, providing tutorial sessions in the fields of medicine and more specifically those fields of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes as they relate to current treatments; Providing continuing medical education courses
Class 042
Clinical research in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Medical research; Medical and scientific research in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of technology in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Scientific research for medical purposes in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Biochemical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Pharmaceutical research and development
Class 044
Clinical medical practice consultation services; Medical clinic services; Medical services; Ophthalmology services; Medical treatment of dry eye and or glaucoma and other ocular disorders; Medical diagnosis and treatment of dry eye and or glaucoma and other ocular disorders
Classification
International Classes
001
003
005
010
025
041
042
044